Literature DB >> 24522995

Thyroidectomy as primary treatment optimizes body mass index in patients with hyperthyroidism.

David F Schneider1, Ratnam Nookala, Taylor J Jaraczewski, Herbert Chen, Carmen C Solorzano, Rebecca S Sippel.   

Abstract

OBJECTIVE: The purpose of this study was to determine how the timing of thyroidectomy influenced postoperative weight change.
METHODS: We conducted a two-institution study, identifying patients treated with total thyroidectomy for hyperthyroidism. Patients were classified as 'early' if they were referred for surgery as the first treatment option, or 'delayed' if they were previously treated with radioactive iodine (RAI). Groups were compared with the Student's t-test or χ (2) test where appropriate.
RESULTS: There were 204 patients undergoing thyroidectomy for hyperthyroidism. Of these, 171 patients were classified as early and 33 were classified as delayed. Overall, patients gained 6.0 % ± 0.8 of their preoperative body weight at last follow-up. Preoperative body mass indexes (BMIs) were similar between groups (p = 0.98), and the median follow-up time was 388 days (range 15-1,584 days). Both groups gained weight until they achieved a normal thyroid-stimulating hormone (TSH) postoperatively. After achieving a normal TSH, the early group stabilized or lost weight (-0.2 lbs/day), while the delayed group continued to gain weight (0.02 lbs/day; p = 0.61). At last follow-up, there were significantly more patients in the delayed group who increased their BMI category compared with the early group (42.4 vs. 21.6 %; p = 0.01). Twice as many patients in the delayed group moved up or into an unhealthy BMI category (overweight or obese) compared with the early group (39.4 vs. 19.3 %; p = 0.01).
CONCLUSIONS: Compared with patients initially treated with RAI, patients with hyperthyroidism who underwent surgery as the first treatment were less likely to become overweight or obese postoperatively.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24522995      PMCID: PMC4277875          DOI: 10.1245/s10434-014-3542-8

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  45 in total

1.  Obesity: the new worldwide epidemic threat to general health and our complete lack of effective treatment.

Authors:  Tina Zimmermann-Belsing; Ulla Feldt-Rasmussen
Journal:  Endocrinology       Date:  2004-04       Impact factor: 4.736

2.  Current trends in the management of Graves' disease.

Authors:  B Solomon; D Glinoer; R Lagasse; L Wartofsky
Journal:  J Clin Endocrinol Metab       Date:  1990-06       Impact factor: 5.958

Review 3.  Neuropeptide regulation of appetite and weight.

Authors:  J E Morley
Journal:  Endocr Rev       Date:  1987-08       Impact factor: 19.871

4.  Weight gain following treatment of hyperthyroidism.

Authors:  J Dale; J Daykin; R Holder; M C Sheppard; J A Franklyn
Journal:  Clin Endocrinol (Oxf)       Date:  2001-08       Impact factor: 3.478

5.  Ghrelin is a growth-hormone-releasing acylated peptide from stomach.

Authors:  M Kojima; H Hosoda; Y Date; M Nakazato; H Matsuo; K Kangawa
Journal:  Nature       Date:  1999-12-09       Impact factor: 49.962

6.  Serum leptin concentrations of patients with sequential thyroid function changes.

Authors:  Ching-Jung Hsieh; Pei-Wen Wang; Shan-Tair Wang; Rue-Tsuan Liu; Shih-Chen Tung; Wen-Yen Chien; Yung-Chuang Lu; Jung-Fu Chen; Chen-Hsiong Chen; Ming-Chun Kuo
Journal:  Clin Endocrinol (Oxf)       Date:  2002-07       Impact factor: 3.478

Review 7.  Ghrelin, appetite, and gastric motility: the emerging role of the stomach as an endocrine organ.

Authors:  Akio Inui; Akihiro Asakawa; Cyril Y Bowers; Giovanni Mantovani; Alessandro Laviano; Michael M Meguid; Mineko Fujimiya
Journal:  FASEB J       Date:  2004-03       Impact factor: 5.191

8.  American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of hyperthyroidism and hypothyroidism.

Authors:  H Jack Baskin; Rhoda H Cobin; Daniel S Duick; Hossein Gharib; Richard B Guttler; Michael M Kaplan; Robert L Segal
Journal:  Endocr Pract       Date:  2002 Nov-Dec       Impact factor: 3.443

9.  The contribution of body composition, substrates, and hormones to the variability in energy expenditure and substrate utilization in premenopausal women.

Authors:  A Astrup; B Buemann; N J Christensen; J Madsen; C Gluud; P Bennett; B Svenstrup
Journal:  J Clin Endocrinol Metab       Date:  1992-02       Impact factor: 5.958

10.  Long-term weight regulation in treated hyperthyroid and hypothyroid subjects.

Authors:  B J Hoogwerf; F Q Nuttall
Journal:  Am J Med       Date:  1984-06       Impact factor: 4.965

View more
  3 in total

Review 1.  Hyperthyroidism.

Authors:  Amanda R Doubleday; Rebecca S Sippel
Journal:  Gland Surg       Date:  2020-02

2.  Weight Gain After Thyroidectomy: A Systematic Review and Meta-Analysis.

Authors:  Christine N Huynh; Janina V Pearce; Le Kang; Francesco S Celi
Journal:  J Clin Endocrinol Metab       Date:  2021-01-01       Impact factor: 5.958

3.  Change in BMI after radioactive iodine ablation for graves disease.

Authors:  Melinda Chen; Matthew Lash; Todd Nebesio; Erica Eugster
Journal:  Int J Pediatr Endocrinol       Date:  2017-06-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.